Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 27Fallopian Tube Neoplasms 9Prostatic Neoplasms 8Breast Neoplasms 8Neoplasms 6Pancreatic Neoplasms 5Endometrial Neoplasms 5Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Mesothelioma 3Lung Neoplasms 3Head and Neck Neoplasms 3Glioblastoma 3Carcinoma, Ovarian Epithelial 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Recurrence 2Mesothelioma, Malignant 2Melanoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Uveal Melanoma 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Thrombocytopenia 1Stomach Neoplasms 1

Interventions

Dexamethasone 12Palonosetron 11Aprepitant 11Ondansetron 8Olanzapine 5Calcium Dobesilate 4netupitant 2fosaprepitant 2Tropisetron 2Radiotherapy 2Fluorouracil 2yangzheng xiaoji 1rolapitant 1ramosetron 1niraparib 1netupitant, palosentron drug combination 1nabiximols 1isatuximab 1ginger extract 1dolasetron 1casopitant 1Yoga 1Therapeutics 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Paclitaxel 1Oxaliplatin 1Octreotide 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nausea × niraparib × Clear all
NCT05641506 2022-12-07

A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown
50 enrolled
Gynecologic

Nausea, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡